These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6239307)

  • 1. Depressor and natriuretic activities of several atrial peptides.
    Tang J; Webber RJ; Chang D; Chang JK; Kiang J; Wei ET
    Regul Pept; 1984 Sep; 9(1-2):53-9. PubMed ID: 6239307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative natriuretic activities of synthetic atriopeptins I, II and III.
    Johnson MD
    Life Sci; 1986 Jan; 38(3):225-31. PubMed ID: 2934602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats.
    Koepke JP; Tyler LD; Trapani AJ; Bovy PR; Spear KL; Olins GM; Blaine EH
    J Pharmacol Exp Ther; 1989 Apr; 249(1):172-6. PubMed ID: 2565386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atriopeptin III alters renal medullary hemodynamics and the pressure-diuresis response in rats.
    Takezawa K; Cowley AW; Skelton M; Roman RJ
    Am J Physiol; 1987 Jun; 252(6 Pt 2):F992-1002. PubMed ID: 2954473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of blood pressure and increased diuresis and natriuresis during chronic infusion of atrial natriuretic factor (ANF Arg 101-Tyr 126) in conscious one-kidney, one-clip hypertensive rats.
    Garcia R; Gutkowska J; Genest J; Cantin M; Thibault G
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):539-45. PubMed ID: 3161083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072.
    Seymour AA; Fennell SA; Swerdel JN
    Hypertension; 1989 Jul; 14(1):87-97. PubMed ID: 2544529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renal response to acute hypervolemia is caused by atrial natriuretic peptides.
    Hirth C; Stasch JP; John A; Kazda S; Morich F; Neuser D; Wohlfeil S
    J Cardiovasc Pharmacol; 1986; 8(2):268-75. PubMed ID: 2422464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasorelaxant and natriuretic activities of synthetic atrial peptides.
    Januszewicz A; Pegram BL; Macphee AA; Cole FE; Kardon MB; Trippodo NC
    Acta Physiol Pol; 1987; 38(6):467-76. PubMed ID: 2969663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of changes in perfusion pressure and angiotensin II on the renal excretory responses to atrial natriuretic peptides.
    Chamienia AL; Johns EJ
    Eur J Pharmacol; 1992 Aug; 218(2-3):319-25. PubMed ID: 1425947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of reduction in renal artery pressure on atrial natriuretic peptide-induced natriuresis.
    Davis CL; Briggs JP
    Am J Physiol; 1987 Jan; 252(1 Pt 2):F146-53. PubMed ID: 2949628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative vascular pharmacology of the atriopeptins.
    Wakitani K; Oshima T; Loewy AD; Holmberg SW; Cole BR; Adams SP; Fok KF; Currie MG; Needleman P
    Circ Res; 1985 Apr; 56(4):621-7. PubMed ID: 3156691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical relationship between atriopeptin plasma levels and diuresis-natriuresis induced by acute volume expansion.
    Sakata M; Greenwald JE; Needleman P
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3155-9. PubMed ID: 2966400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intracerebroventricular atrial natriuretic polypeptide on blood pressure and urine production in rats.
    Shimizu T; Katsuura G; Nakamura M; Nakao K; Morii N; Itoh Y; Shiono S; Imura H
    Life Sci; 1986 Oct; 39(14):1263-70. PubMed ID: 2945065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Swerdel JN; Little DK; Dorso CR
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilator properties of a family of bioactive atrial peptides in isolated perfused rat kidneys.
    Wakitani K; Currie MG; Geller DM; Needleman P
    J Lab Clin Med; 1985 Mar; 105(3):349-52. PubMed ID: 3156197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of alpha-human atrial natriuretic polypeptide (alpha-hANP) in rats.
    Sasaki A; Kida O; Kangawa K; Matsuo H; Tanaka K
    Eur J Pharmacol; 1985 Mar; 109(3):405-7. PubMed ID: 3157588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natriuretic and hypotensive effects of alpha-human atrial natriuretic polypeptide in anaesthetized DOCA-salt hypertensive rats.
    Kondo K; Kida O; Kangawa K; Matsuo H; Tanaka K
    Clin Exp Pharmacol Physiol; 1986 Feb; 13(2):97-101. PubMed ID: 2940041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aldosterone biosynthesis by atriopeptins in rat adrenal cells.
    Campbell WB; Currie MG; Needleman P
    Circ Res; 1985 Jul; 57(1):113-8. PubMed ID: 2988817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary clearance of atrial natriuretic peptides.
    Numan NA; Gillespie MN; Altiere RJ
    Pulm Pharmacol; 1990; 3(1):25-8. PubMed ID: 2152026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atriopeptins: a family of potent biologically active peptides derived from mammalian atria.
    Geller DM; Currie MG; Wakitani K; Cole BR; Adams SP; Fok KF; Siegel NR; Eubanks SR; Galluppi GR; Needleman P
    Biochem Biophys Res Commun; 1984 Apr; 120(2):333-8. PubMed ID: 6233969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.